This article is more than 5 years old. Information may no longer be current.

BioTime rebrands as Lineage Cell Therapeutics

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BioTime has changed its name to Lineage Cell Therapeutics to better reflect its commitment to becoming a leading cell therapy company, according to a press release.

“It has been less than 1 year since I joined the company, and I’m excited that we have largely completed the strategic and multifaceted plan to simplify our business structure and reposition ourselves as one of the most promising and focused cell therapy companies,” Brian M. Culley, the company’s CEO, said in the release

Lineage Cell Therapeutics’ NYSE American ticker symbol is LCTX, and the company has relocated its corporate headquarters to Carlsbad, California.

“We look forward to inviting stakeholders to rediscover what sets us apart from other companies and to join us as we embark on the next step of this exciting journey. Control the lineage of cells; don’t leave it up to fate,” Culley said.